Table 1

Characteristics of the patients with WG

Patient No	Sex	Age (years)	Disease activity	C reactive protein (mg/l)	ESR (mm/1st h)	Drugs
ESR, erythrocyte sedimentation rate; Pred, prednisolone; IVIg, intravenous immunoglobulin; TMP/SMX, trimetroprim/sulfamethoxazole; CYC, cyclophosphamide; etan, etanercept; bid, twice a day; qd, every day.
1	Male	27	Remission	8	7	IVIg
2	Female	65	Remission	<5	9	Pred 10 mg qd
3	Male	41	Remission	10	21	Pred 10 mg qd
4	Male	33	Remission	<5	18	Pred 5 mg qd
5	Female	31	Remission	<5	10	TMP/SMX
6	Female	52	Remission	5	8	-
7	Male	59	Remission	5	17	TMP/SMX
8	Female	37	Remission	<5	11	Pred 10 mg qd
9	Female	35	Active	14	110	Pred 20 mg bid, CYC
10	Male	28	Active	29	61	Pred 15 mg qd, CYC
11	Male	58	Active	161	100	Pred 15 mg qd, etan
12	Female	84	Active	45	53	Pred 20 mg bid, CYC
13	Female	56	Active	62	96	Pred 20 mg qd, CYC
14	Female	35	Active	57	30	Pred 20 mg bid, IVIg
15	Male	58	Active	16	47	Pred 20 mg qd, CYC